Bristol Myers
Jun 18, 2011 at 15:17 | Source: CNBC-TV18
Oct 27, 2010 at 08:14 | Source: Reuters
Oct 18, 2010 at 19:14 | Source: CNBC-TV18
Oct 09, 2010 at 11:13 | Source: Reuters
Oct 07, 2010 at 08:24 | Source: Reuters
Interact & exchange stock tips & market info »
Related News »
Tick-tock, tick-tock, tick-tock ... It was only a matter of time before Plavix, Bristol-Myers Squibb's best-selling blood-clot-fighting drug, was set to lose patent protection. Well, folks, that day has come and gone as of last Thursday, and one ...
May 20, 2012 at 15:55 | Source: msnbc.com
Bristol-Myers Squibb Company (BMS) discovers, develops, licenses, manufactures and markets biopharmaceuticals and related healthcare products. It principally offers products in the fields of cancer, infectious diseases, psychiatry disorders, diabetes ...
May 20, 2012 at 18:11 | Source: Transworld News
Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial production of ORENCIA ® (abatacept).
May 16, 2012 at 08:43 | Source: News-Medical.Net
Bristol-Myers Squibb Company (BMY) will take part in Sanford Bernstein’s 28th Annual Strategic Decisions Conference on Thursday, May 31, 2012, in New York. Lamberto Andreotti, chief executive officer, will answer questions about the company at ...
May 24, 2012 at 14:10 | Source: Yahoo Finance
For more than 80 years, as University Medical Center at Princeton, a respected teaching hospital, was expanding and evolving, one constant was the presence of a Clinic providing free or low-cost care to central New Jersey residents who need it.
May 22, 2012 at 19:20 | Source: Packet Online
Bristol-Myers Squibb Company (NYSE:BMY - News) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s biologics manufacturing facility in Devens, Massachusetts for commercial production of ORENCIA ...
May 26, 2012 at 00:32 | Source: Yahoo Finance
Pharmaceuticals giant Bristol Myers Squibb Co. (BMY) on Friday caught some bullish commentary from analysts at BMO Capital. The firm initiated coverage on BMY with an “Outperform” rating and $39 price target, which suggests a 19% upside to ...
May 18, 2012 at 13:06 | Source: dividend.com
J&J shares rose less than 1% in morning trading Thursday. The stock is down 4% this year. J&J, its development partner Bayer, Pfizer, and Bristol-Myers are chasing rival Boehringer Ingelheim, which began selling Pradaxa in the US last year.
May 24, 2012 at 14:17 | Source: Minyanville
Takeda Pharmaceutical Co. and Bristol-Myers Squibb Co. (BMY) indicated to Amylin they also would make bids, the people said. Amylin began looking for suitors with Credit Suisse Group AG and Goldman Sachs Group Inc. after rejecting a $3.5 billion ...
May 25, 2012 at 17:58 | Source: Bloomberg
SHANGHAI, China, May 15, 2012 (BUSINESS WIRE) -- The Bristol-Myers Squibb Foundation today announced the expansion of its Together on Diabetes(R) initiative to China and India, pledging $15 million over five years to help these developing nations with ...
May 15, 2012 at 13:59 | Source: CNBC